Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BBC's Catrin Nye visited the Oxford Vaccine Group to find out about the quest for an Ebola vaccine.

The Oxford Vaccine Group (OVG) is part of the University of Oxford's Department of Paediatrics.

Victoria Derbyshire's daily news and current affairs programme went to the Oxford lab to find out about what trial participants are doing to help, and to speak to OVG Director, Andy Pollard, about his groundbreaking work.

Watch the clip here.

See the full programme here.

Similar stories

The global value of vaccination

We recently worked with Mediaplanet on the 2019 Health Awareness: Value of Vaccines campaign. The campaign features exclusive content from key thought leaders and industry voices about the critical importance of full immunisation throughout life.

Typhoid vaccine set to have 'huge impact'

A new vaccine that could prevent up to nine-in-10 cases of typhoid fever has been recommended by the World Health Organization. By James Gallagher, Health and science reporter, BBC News website

OSPREA and OVG's recruitment success for study of maternal vaccines against RSV

The Oxford Safer Pregnancy Alliance [OSPREA] and the Oxford Vaccine Group [OVG] have recently undertaken a successful recruitment drive for a study of maternal immunisation to prevent infant Respiratory Syncytial Virus [RSV] infection.

Winners at the Thames Valley Health Research Awards

Hannah Robinson and Sarah Loving from the Department of Paediatrics were recognised in the annual awards hosted by the Thames Valley Clinical Research Network

Understanding RSV, a major cause of respiratory illness in infants.

Respiratory Syncytial Virus (RSV) is one of the most common reasons for young infants to be admitted to hospital, and globally is second only to malaria as a cause of death in infants between 1 and 12 months of age. In the UK it mostly occurs from October to February, causing a wave of infections that stretch the capacity of children’s wards to their limits.

Oxford vaccine test volunteers infected with typhoid

The Oxford Vaccine Group, part of University of Oxford, gave 99 volunteers a drink laced with live Salmonella Typhi bacteria a month after vaccinating them. Between 40% and 50% of the volunteers for the trial were students, Healthcare professionals were allowed to take part if they were not in patient-facing jobs or if they were willing to take around 3-4 weeks off work to be infected